NanoViricides begins work on coronavirus
Shelton’s NanoViricides is advancing its skin cream for the shingles virus and working on a treatment for the deadly coronavirus. The company, which develops so-called...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
Shelton’s NanoViricides is advancing its skin cream for the shingles virus and working on a treatment for the deadly coronavirus. The company, which develops so-called...
A massive analysis of the entire genomes of 2,658 people with 39 different types of cancer has identified mutations in 179 genes and gene regulators...
Shoreline Biome recently unveiled a novel DNA isolation product. Shoreline Rapid Prep is a fast and easy-to-use kit designed for efficient and unbiased isolation of high...
A fascination with viruses has driven Ashley Kalinauskas, who now heads a team of about 10 Torigen employees at UConn’s Cell and Genome Sciences Building...
A Guilford startup founded by nationally known Connecticut serial entrepreneur Jonathan Rothberg will become the first company to sell a bedside MRI machine after getting...
The Connecticut Economic Resource Center (CERC), the economic- and market-research affiliate of the Department of Economic and Community Development, has rebranded as AdvanceCT. The rebranding...
Bristol-Myers Squibb and BioMotiv have launched Anteros Pharmaceuticals, a biotechnology company focused on developing a new class of drugs for fibrotic and other inflammatory diseases....
Biohaven Pharmaceuticals has pulled the plug on developing its experimental drug for anxiety after the compound performed poorly in a clinical trial. Separately, New Haven...
Rebiotix, a Ferring company, has completed enrollment of the pivotal Phase 3 clinical trial for RBX2660, an investigational therapy aimed at breaking the cycle of...
BioXcel Therapeutics reports that its Investigational New Drug application for BXCL501, the Company’s proprietary sublingual thin-film formulation of dexmedetomidine, has received clearance from the FDA...